Preclinical safety studies of the drug with nootropic activity, based on the amide form of the leukocytes differentiation factor fragmentстатья
Информация о цитировании статьи получена из
Scopus
Статья опубликована в журнале из перечня ВАК
Статья опубликована в журнале из списка Web of Science и/или Scopus
Дата последнего поиска статьи во внешних источниках: 20 апреля 2022 г.
Аннотация:Preclinical studies on systemic toxicity and allergenic properties of amide form of HLDF-6 peptide in order to study the safety of its use as a drug with nootropic activity when administered intranasally were conducted. Studies were performed on male and female SD (Sprague Dawley) rats and CD-1 mice. Test results have demonstrated a lack of toxic effects of the study drug at the doses used in this rote of administration.